PC-FACS
PCFACS Home | Issues | Advanced Search |
January
The antibody aducanumab reduces Aβ plaques in Alzheimer's disease |
Sevigny J, Chiao P, Bussiere T, et al |
Antibodies Reduce Aβ Plaques in Alzheimer's Disease Background: Alzheimer’s disease (AD) is partly characterized by amyloid-β (Aβ)-related toxicity and acco... |
>> Continue Reading |
Palliative care consultations in nursing homes and reductions in acute care use and potentially burdensome end-of-life transitions |
Miller SC, Lima JC, Intrator O, Martin E, Bull J, Hanson LC |
Using Palliative Care for End-of-Life Transitions in Nursing Homes Background: Nursing home (NH) access to palliative care (PC) often is lacking.1-2 How do NH PC consultations aff... |
>> Continue Reading |
Geographic concentration of home-based medical care providers |
Yao N, Ritchie C, Camacho F, Leff B |
Geographic Concentration of Home-Based Medical Care Providers Background: The United States faces a shortage of home-based medical care (HBMC) providers.1-2 What geographic disp... |
>> Continue Reading |
Intimacy, substance use, and communication needs during cancer therapy: a report from the |
Rosenberg AR, Bona K, Ketterl T, Wharton CM, Wolfe J, Baker KS |
Intimacy, Substance Use, and Communication Needs Among AYA With Cancer Background: Little is known about adolescents and young adults’ (AYA) health behaviors during can... |
>> Continue Reading |
Screening for depression in cancer patients receiving radiotherapy: feasibility and identification of effective tools in the NRG Oncology RTOG 0841 Trial. [published online ahead of print Nov 10 2016] |
Wagner LI, Pugh SL, Small W Jr, et al |
Screening for Depression in Cancer Patients Receiving Radiotherapy Background: Identifying patients’ psychosocial health needs is crucial to quality cancer care.1 Can ... |
>> Continue Reading |
Relationships between oxycodone pharmacokinetics, central symptoms, and serum interleukin-6 in cachectic cancer patients |
Sato H, Naito T, Ishida T, Kawakami J |
Cachectic Cancer Patients and the Use of Oxycodone Background: Oxycodone is commonly administered for cancer pain.1 How do oxycodone pharmacokinetics, central symptom... |
>> Continue Reading |
PCFACS Home | Issues | Advanced Search |
For questions regarding this publication, send an email to resources@aahpm.org or call 847/375-4712.